| Literature DB >> 41543 |
M M Mitler, M A Carskadon, R L Phillips, W R Sterling, V P Zarcone, R Spiegel, C Guilleminault, W C Dement.
Abstract
1 Temazepam was evaluated in a strictly defined insomniac patient population under sleep laboratory conditions. Two protocols were used: a short-term (26-night) and a long-term (54-night) protocol evaluated the efficacy of the drug administered at night at 15 mg (short-term study) and 30 mg (long-term study), respectively. 2 Temazepam seemed to be both safe and effective at doses of 15 and 30 mg with up to 5 weeks of ingestion. 3 Suppression of slow wave sleep was observed at the high dose, but no suppression of REM sleep, found in studies with other benzodiazepines, was noted. 4 No evidence was found for development of tolerance or rebound effects.Entities:
Mesh:
Substances:
Year: 1979 PMID: 41543 PMCID: PMC1429637 DOI: 10.1111/j.1365-2125.1979.tb00459.x
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 4.335